Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Parkinson's Disease

Free Subscription 11.11.2019 1 Brain Res 1 J Clin Psychopharmacol 1 J Neurochem 1 Lancet Neurol 3 Mov Disord 1 Nat Med 1 Nat Rev Neurol 1 Neurobiol Dis 1 Neuron 1 Neurosci Lett 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Brain Res

1. BINDA KH, Real CC, Ferreira AFF, Britto LRG, et al
   Antinociceptive effects of treadmill exercise in a rat model of Parkinson's disease: the role of cannabinoid and opioid receptors.
   Brain Res. 2019 Nov 4:146521. doi: 10.1016/j.brainres.2019.146521.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Psychopharmacol

2. SANAGAWA A, Shiraishi N, Sekiguchi F, Akechi T, et al
   Successful Use of Brexpiprazole for Parkinson's Disease Psychosis Without Adverse Effects: A Case Report.
   J Clin Psychopharmacol. 2019 Oct 29. doi: 10.1097/JCP.0000000000001127.
   PubMed     Text format    
   
   

   
   J Neurochem

3. COGO S, Manzoni C, Lewis PA, Greggio E, et al
   Leucine-rich repeat kinase 2 and lysosomal dyshomeostasis in Parkinson disease.
   J Neurochem. 2019 Nov 6. doi: 10.1111/jnc.14908.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Neurol

4. SIMUNI T, Uribe L, Cho HR, Caspell-Garcia C, et al
   Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
   Lancet Neurol. 2019 Oct 30. pii: S1474-4422(19)30319.
   PubMed     Text format     Abstract available
   
   

   
   Mov Disord

5. HAQUE ME, Akther M, Jakaria M, Kim IS, et al
   Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease.
   Mov Disord. 2019 Nov 4. doi: 10.1002/mds.27874.
   PubMed     Text format     Abstract available
   
   
6. PETRILLO S, Schirinzi T, Di Lazzaro G, D'Amico J, et al
   Systemic activation of Nrf2 pathway in Parkinson's disease.
   Mov Disord. 2019 Nov 4. doi: 10.1002/mds.27878.
   PubMed     Text format     Abstract available
   
   
7. LAWTON M, Baig F, Toulson G, Morovat A, et al
   Blood biomarkers with Parkinson's disease clusters and prognosis: the oxford discovery cohort.
   Mov Disord. 2019 Nov 6. doi: 10.1002/mds.27888.
   PubMed     Text format     Abstract available
   
   

   
   Nat Med

8. JAMESON KG, Hsiao EY
   A novel pathway for microbial metabolism of levodopa.
   Nat Med. 2019;25:1195-1197.
   PubMed     Text format    
   
   

   
   Nat Rev Neurol

9. FYFE I
   A clinically useful MRI marker of PD?
   Nat Rev Neurol. 2018 Nov 22. pii: 10.1038/s41582-018-0109.
   PubMed     Text format    
   
   

   
   Neurobiol Dis

10. MILLOT M, Saga Y, Duperrier S, Metereau E, et al
    Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys.
    Neurobiol Dis. 2019 Nov 2:104643. doi: 10.1016/j.nbd.2019.104643.
    PubMed     Text format     Abstract available
    
    

    
    Neuron

11. KONEN C, Niederst E
    Special Issue on Disease: Mechanisms of Disease.
    Neuron. 2019;101:997.
    PubMed     Text format    
    
    

    
    Neurosci Lett

12. CHEN W, Yan X, Lv H, Liu Y, et al
    Gender differences in prevalence of LRRK2-associated Parkinson diseaseA meta-analysis of observational studies.
    Neurosci Lett. 2019 Nov 4:134609. doi: 10.1016/j.neulet.2019.134609.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

13. LEI C, Sunzi K, Dai F, Liu X, et al
    Effects of virtual reality rehabilitation training on gait and balance in patients with Parkinson's disease: A systematic review.
    PLoS One. 2019;14:e0224819.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: